528 related articles for article (PubMed ID: 23936064)
1. Toward repurposing ciclopirox as an antibiotic against drug-resistant Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae.
Carlson-Banning KM; Chou A; Liu Z; Hamill RJ; Song Y; Zechiedrich L
PLoS One; 2013; 8(7):e69646. PubMed ID: 23936064
[TBL] [Abstract][Full Text] [Related]
2. Sugar and iron: Toward understanding the antibacterial effect of ciclopirox in Escherichia coli.
Conley ZC; Carlson-Banning KM; Carter AG; de la Cova A; Song Y; Zechiedrich L
PLoS One; 2019; 14(1):e0210547. PubMed ID: 30633761
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic resistance in gram-negative bacilli: a Singapore perspective.
Tan TY; Hsu LY; Koh TH; Ng LS; Tee NW; Krishnan P; Lin RT; Jureen R
Ann Acad Med Singap; 2008 Oct; 37(10):819-25. PubMed ID: 19037514
[TBL] [Abstract][Full Text] [Related]
4. Role of acid responsive genes in the susceptibility of Escherichia coli to ciclopirox.
Shin J; Cho H; Kim S; Kim KS
Biochem Biophys Res Commun; 2018 Jun; 500(2):296-301. PubMed ID: 29654752
[TBL] [Abstract][Full Text] [Related]
5. In vitro Activity of Sitafloxacin and Other Antibiotics against Bacterial Isolates from HRH Princess Maha Chakri Sirindhorn Medical Center, Srinakharinwirot University and Samitivej Sukhumvit Hospital.
Tantisiriwat W; Linasmita P
J Med Assoc Thai; 2017 Apr; 100(4):469-78. PubMed ID: 29912484
[TBL] [Abstract][Full Text] [Related]
6.
Lee B; Yan J; Ulhaq A; Miller S; Seo W; Lu P; She R; Spellberg B; Luna B
mSphere; 2021 Dec; 6(6):e0092021. PubMed ID: 34817233
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamic comparisons of antimicrobials against nosocomial isolates of escherichia coli, klebsiella pneumoniae, acinetobacter baumannii and pseudomonas aeruginosa from the MYSTIC surveillance program: the OPTAMA Program, South America 2002.
Kiffer CR; Mendes C; Kuti JL; Nicolau DP
Diagn Microbiol Infect Dis; 2004 Jun; 49(2):109-16. PubMed ID: 15183860
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial resistance patterns among critical priority pathogens in an intensive care unit at a tertiary hospital in Egypt: a descriptive analysis comparing pre- and COVID-19 eras.
Zafer MM; Bassiouny DM; Ghosh S; Bornman C; Hussein AFA
J Med Microbiol; 2024 Jun; 73(6):. PubMed ID: 38916589
[No Abstract] [Full Text] [Related]
9. Antimicrobial resistance patterns of Gram-negative bacteria isolated from bloodstream infections in an Iranian referral paediatric hospital: A 5.5-year study.
Mahmoudi S; Mahzari M; Banar M; Pourakbari B; Haghi Ashtiani MT; Mohammadi M; Keshavarz Valian S; Mamishi S
J Glob Antimicrob Resist; 2017 Dec; 11():17-22. PubMed ID: 28729206
[TBL] [Abstract][Full Text] [Related]
10. In vitro evaluation of ciclopirox as an adjuvant for polymyxin B against gram-negative bacteria.
Kim KS; Kim T; Pan JG
J Antibiot (Tokyo); 2015 Jun; 68(6):395-8. PubMed ID: 25586022
[No Abstract] [Full Text] [Related]
11. Preservation of Acquired Colistin Resistance in Gram-Negative Bacteria.
Lee JY; Choi MJ; Choi HJ; Ko KS
Antimicrob Agents Chemother; 2016 Jan; 60(1):609-12. PubMed ID: 26459897
[TBL] [Abstract][Full Text] [Related]
12. Adjunctive transferrin to reduce the emergence of antibiotic resistance in Gram-negative bacteria.
Luna BM; Ershova K; Yan J; Ulhaq A; Nielsen TB; Hsieh S; Pantapalangkoor P; Vanscoy B; Ambrose P; Rudin S; Hujer K; Bonomo RA; Actis L; Skaar EP; Spellberg B
J Antimicrob Chemother; 2019 Sep; 74(9):2631-2639. PubMed ID: 31170282
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence High-Throughput Screening for Inhibitors of TonB Action.
Nairn BL; Eliasson OS; Hyder DR; Long NJ; Majumdar A; Chakravorty S; McDonald P; Roy A; Newton SM; Klebba PE
J Bacteriol; 2017 May; 199(10):. PubMed ID: 28242720
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic spectrum of blood stream infections and resistance pattern in Gram-negative bacteria from Aljouf region of Saudi Arabia.
Bandy A; Almaeen AH
PLoS One; 2020; 15(6):e0233704. PubMed ID: 32516308
[TBL] [Abstract][Full Text] [Related]
15. Isothermal microcalorimetry minimal inhibitory concentration testing in extensively drug resistant Gram-negative bacilli: a multicentre study.
Tellapragada C; Hasan B; Antonelli A; Maruri A; de Vogel C; Gijón D; Coppi M; Verbon A; van Wamel W; Rossolini GM; Cantón R; Giske CG
Clin Microbiol Infect; 2020 Oct; 26(10):1413.e1-1413.e7. PubMed ID: 32006694
[TBL] [Abstract][Full Text] [Related]
16. High rates of plasmid-mediated quinolone resistance QnrB variants among ciprofloxacin-resistant Escherichia coli and Klebsiella pneumoniae from urinary tract infections in Korea.
Shin JH; Jung HJ; Lee JY; Kim HR; Lee JN; Chang CL
Microb Drug Resist; 2008 Sep; 14(3):221-6. PubMed ID: 18707554
[TBL] [Abstract][Full Text] [Related]
17. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
[TBL] [Abstract][Full Text] [Related]
18. Exploring bacterial resistance in Northern Oman, a foundation for implementing evidence-based antimicrobial stewardship program.
Al Rahmany D; Albeloushi A; Alreesi I; Alzaabi A; Alreesi M; Pontiggia L; Ghazi IM
Int J Infect Dis; 2019 Jun; 83():77-82. PubMed ID: 30959249
[TBL] [Abstract][Full Text] [Related]
19. Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens.
Pollini S; Brunetti J; Sennati S; Rossolini GM; Bracci L; Pini A; Falciani C
J Pept Sci; 2017 Apr; 23(4):329-333. PubMed ID: 28176481
[TBL] [Abstract][Full Text] [Related]
20. Resistance to polymyxins in Gram-negative organisms.
Jeannot K; Bolard A; Plésiat P
Int J Antimicrob Agents; 2017 May; 49(5):526-535. PubMed ID: 28163137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
